Aurobindo Pharma

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE406A01037
  • NSEID: AUROPHARMA
  • BSEID: 524804
INR
1,226.15
51.05 (4.34%)
BSENSE

Feb 03

BSE+NSE Vol: 30.96 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryAurobindo Pharma VS Pharmaceuticals & Biotechnology
 
1D
4.34%
2.54%
1W
8.49%
2.3%
1M
1.02%
-2.36%
YTD
3.81%
-1.74%
1Y
8.8%
8.49%
3Y
203.58%
37.63%
5Y
33.27%
66.63%
10Y
59.06%
245.7%
  • Stock Absolute Returns
  • Absolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0.34%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
5.88%
0%
5.88%
6 Months
13.56%
0.37%
13.93%
1 Year
8.8%
0.34%
9.14%
2 Years
14.99%
0.55%
15.54%
3 Years
203.58%
1.83%
205.41%
4 Years
82.87%
2.64%
85.51%
5 Years
33.27%
2.35%
35.62%

Latest dividend: 4 per share ex-dividend date: Aug-08-2025

stock-summaryReturn Quartiles
What is a Quartile?

Quartile analysis gives a quick view of the performance of the stock with its peers and with the overall market. Companies are bucketed in 4 Quartiles as per their total returns generated; with each quartile consisting of 25% of the companies in the category.


Example: If there are 20 companies in an industry, the top 5 return giving companies would be bucketed in 1st quartile, next 5 companies in 2nd quartile and so on

Return Quartiles - by Closest Peers stock-summary
Icon
Not enough Stock Price history for Quartile Analysis
Return Quartiles - by Industry stock-summary
Icon
Not enough Stock Price history for Quartile Analysis
Return Quartiles - by Market Cap stock-summary
Icon
Not enough Stock Price history for Quartile Analysis
stock-summaryRisk Adjusted Returns v/s
Risk Adjusted Returns v/s stock-summary
stock-summaryReturns Beta
Returns Beta
Icon
Beta has not been calculated since enough price history is not available